Faecal Extraction System Market Trends

Growth Drivers

• An increase in the incidence of gastrointestinal diseases: The need for the market is highly fueled by an upsurge in inflammatory bowel disease, along with colorectal cancer. According to an article published by the Gastro Organization in September 2022, almost 40% of the population in America readily restricted routine activities, owing to uncomfortable bowel symptoms, including 19% exercise, 17% running errands, and 16% time spent with friends and families. In addition, an estimated 60 to 70 million people in the overall region are effectively suffering from gastrointestinal diseases, which has created severe disruptions in regular life, thereby bolstering the market’s demand.
• Technological automation and innovation: The significant inclination towards implementing DNA-based solutions is one of the most suitable growth factors for the market internationally. Different organizations are readily partnering with tech-specific companies to develop cloud-based diagnostic platforms. As stated in the January 2025 World Economic Forum article, a single-payer system is readily utilized in Taiwan by researchers to diminish the time undertaken to complete tasks by 31%. Besides, autonomous robotic vehicles have been incorporated in the U.S. to deliver pharmaceuticals in hospitals, thereby uplifting the overall market globally.
• Increased focus on patient dignity: There is an increasing recognition in the global healthcare and medical community regarding the importance of preserving patient dignity, which is positively impacting the market. Faecal extraction systems provide a dignified management service to enhance patients' lives, which in turn, is surging purchase decisions. As indicated in the November 2022 NLM article, chromatographic separation was readily conducted on a Vanquish Accucore C18 + UNPLC analytical column, which denoted a 400 μL, while electrospray ionization was also utilized as a ionization approach, which was set at 3,900 V and 2,500 V, demonstrating the usefulness of these systems.

Colorectal Cancer Incidence Driving the Market

Source: National Cancer Institute

Challenges

• Reimbursement gaps and government-based price caps: The presence of strict price control from the NHS has readily compelled different manufacturers to negotiate discounts for products to get reimbursed, which has caused a hindrance in the market. However, BÜHLMANN successfully outmaneuvered the challenge by effectively partnering with the HAS, which is located in France, to significantly increase the market accessibility. Apart from this, the World Health Organization (WHO) has reported that the majority of low-income nations lack standard reimbursement policies, which also negatively impacts the market.
• Prolonged and strict administrative approvals: This is yet another challenge that has limited the market’s growth across different countries. In this regard, the presence of the Pharmaceuticals and Medical Devices Agency, particularly in Japan, has readily caused a delay in gaining approval of FES devices from ALPCO for more than a year. Besides, the WHO has indicated that more than half of the population in Africa lacks standardization, which has resulted in a delay of over two years for achieving entry into the current marketplace, thereby limiting the market’s exposure internationally.